Drug firm Cipla ties up with Roche Pharma to distribute cancer drugs in India

Vastavam web: Drug firm Cipla today said it has entered into an agreement with Roche Pharma to promote and distribute the latter’s cancer drugs in India.The pharma major will distribute Tocilizumab and Syndyma — the second brand of Roche’s cancer therapy bevacizumab — in India.Commenting on the development, Cipla MD & Global CEO Umang Vohra said: “The prevalence of cancer and rheumatoid arthritis is widely spread across India, and Cipla can contribute to provide broader access to innovative medicines like tocilizumab and bevacizumab.”

“At Roche, improving access to the critical medicines that patients need is an integral part of what we do,” Roche Pharma India MD Lara Bezerra said.This will also enable Roche to focus on bringing new, transformative medicines to patients in India, Bezerra said.